Sei Investments Co. lifted its holdings in HCP, Inc. (NYSE:HCP) by 79.7% during the second quarter, HoldingsChannel.com reports. The fund owned 930,263 shares of the real estate investment trust’s stock after buying an additional 412,653 shares during the quarter. Sei Investments Co.’s holdings in HCP were worth $24,019,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors have also added to or reduced their stakes in the company. Piedmont Investment Advisors LLC acquired a new stake in shares of HCP in the second quarter worth $142,000. Archford Capital Strategies LLC acquired a new stake in shares of HCP in the first quarter worth $167,000. Reliance Trust Co. of Delaware acquired a new stake in shares of HCP in the second quarter worth $211,000. Atlas Brown Inc. acquired a new stake in shares of HCP in the second quarter worth $226,000. Finally, Advisor Partners LLC acquired a new stake in shares of HCP in the first quarter worth $228,000. Hedge funds and other institutional investors own 89.41% of the company’s stock.
Shares of HCP opened at $25.98 on Friday, according to Marketbeat Ratings. HCP, Inc. has a 1 year low of $21.48 and a 1 year high of $30.59. The firm has a market cap of $12.29 billion, a P/E ratio of 13.70, a PEG ratio of 4.80 and a beta of 0.30. The company has a current ratio of 0.51, a quick ratio of 0.51 and a debt-to-equity ratio of 1.37.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, August 21st. Shareholders of record on Wednesday, August 8th will be issued a dividend of $0.37 per share. This represents a $1.48 annualized dividend and a yield of 5.70%. The ex-dividend date of this dividend is Friday, August 3rd. HCP’s payout ratio is 75.90%.
A number of analysts have recently weighed in on HCP shares. Capital One Financial started coverage on shares of HCP in a research note on Tuesday, July 24th. They issued an “equal weight” rating and a $27.50 price objective on the stock. Morgan Stanley lowered their price target on shares of HCP from $28.00 to $23.50 and set an “equal weight” rating on the stock in a report on Thursday, June 14th. Zacks Investment Research downgraded shares of HCP from a “hold” rating to a “sell” rating in a report on Tuesday, July 31st. Raymond James downgraded shares of HCP from an “outperform” rating to a “market perform” rating in a report on Monday, May 21st. Finally, BMO Capital Markets reissued a “hold” rating and set a $25.00 price target on shares of HCP in a report on Thursday, May 3rd. Two analysts have rated the stock with a sell rating, twelve have issued a hold rating and four have issued a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $25.93.
In related news, Director R Kent Griffin, Jr. acquired 21,100 shares of the firm’s stock in a transaction on Monday, May 14th. The shares were acquired at an average cost of $23.80 per share, with a total value of $502,180.00. Following the completion of the acquisition, the director now directly owns 30,575 shares in the company, valued at approximately $727,685. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Company insiders own 0.14% of the company’s stock.
HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.
Read More: Price to Earnings Ratio (PE)
Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).
Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.